INTERNATIONAL SOCIETY FOR THE STUD… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1981

Legal Domicile

Principal Officer

ZOE FULLER

Phone

2023671160

Tax Period

2023-01-01 to 2023-12-31

INTERNATIONAL SOCIETY FOR THE STUDY OF XENOBIOTICS, founded in 1981, is a community nonprofit in the Science & Technology sector that reported $1.4M in total revenue in fiscal year 2023. Revenue surged 90% from the prior year, signaling strong growth momentum. Expenses of $1.3M left a modest 8% surplus.

Mission

ISSX IS AN INTERNATIONAL ASSOCIATION OF SCIENTISTS THAT PROMOTES THE UNDERSTANDING OF THE INTERACTIONS OF MEDICINES AND CHEMICALS WITH LIVING SYSTEMS.

Program Service Accomplishments

Program 1

Expenses: $917,021 Revenue: $1,219,654

SCIENTIFIC MEETINGS - ISSX ORGANIZES DOMESTIC AND INTERNATIONAL SCIENTIFIC MEETINGS TO BRING TOGETHER RESEARCHERS TO ADVANCE THEIR KNOWLEDGE ON THE INTERPLAY OF LIVING SYSTEMS WITH MEDICINES AND...

SCIENTIFIC MEETINGS - ISSX ORGANIZES DOMESTIC AND INTERNATIONAL SCIENTIFIC MEETINGS TO BRING TOGETHER RESEARCHERS TO ADVANCE THEIR KNOWLEDGE ON THE INTERPLAY OF LIVING SYSTEMS WITH MEDICINES AND CHEMICALS.

Program 2

Expenses: $86,276 Revenue: $68,070

OTHER PROGRAMS - ISSX AWARD PROGRAMS RECOGNIZE SCIENTIFIC AND SERVICE ACHIEVEMENTS THROUGH THE INTERNATIONAL DISTINGUISHED SCIENTIFIC ACHIEVEMENT AND DISTINGUISHED SERVICE AWARDS, THE REGIONAL...

OTHER PROGRAMS - ISSX AWARD PROGRAMS RECOGNIZE SCIENTIFIC AND SERVICE ACHIEVEMENTS THROUGH THE INTERNATIONAL DISTINGUISHED SCIENTIFIC ACHIEVEMENT AND DISTINGUISHED SERVICE AWARDS, THE REGIONAL SCIENTIFIC AND NEW INVESTIGATOR AWARDS, AND OTHER ACTIVITIES TO PROMOTE RESEARCH AND THE DISSEMINATION OF INFORMATION CONCERNING THE INTERPLAY OF LIVING SYSTEMS WITH MEDICINES AND CHEMICALS.

Program 3

Expenses: $38,317

LEADERSHIP - ISSX FOSTERS AND ENCOURAGES THE EXCHANGE OF INFORMATION AMONGST RESEARCHERS ON INTERDISCIPLINARY AND INNOVATIVE SCIENCE RELATED TO THE DISPOSITION, METABOLISM, AND BIOLOGICAL EFFECTS OF...

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $66,915

Program Service Revenue $1,291,636

Investment Income $65,960

Other Revenue $2,400

TOTAL REVENUE $1,426,911

Expense Breakdown

Grants Paid $19,515

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $1,041,614

Other Expenses $1,299,539

TOTAL EXPENSES $1,319,054

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,426,911	$752,876	+0.9%
Expenses	$1,319,054	$833,569	+0.6%
Net Income	$107,857	$-80,693	-2.3%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SCOTT OBACH	PRESIDENT	4.00	Officer Director	$0	$0	$0
ALEKSANDRA GALETIN	PRESIDENT-ELECT/SECRETARY	4.00	Officer Director	$0	$0	$0
SANDY PANG	TREASURER	1.00	Officer Director	$0	$0	$0
MARY PAINE	TREASURER-ELECT	1.00	Officer Director	$0	$0	$0
UWE FUHR	COUNCIL MEMBER	1.00	Director	$0	$0	$0
KIYOMI ITO	COUNCIL MEMBER	1.00	Director	$0	$0	$0
NINA ISOHERRANEN	COUNCIL MEMBER	1.00	Director	$0	$0	$0
SIMONE SCHADT	COUNCIL MEMBER	1.00	Director	$0	$0	$0
SWATI NAGAR	COUNCIL MEMBER	1.00	Director	$0	$0	$0
HIROSHI YAMAZAKI	COUNCIL MEMBER	1.00	Director	$0	$0	$0
ZOE FULLER	EXECUTIVE DIRECTOR	20.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,426,911	$1,319,054	$1,415,457	$107,857
2022	$752,876	$833,569	$1,171,996	$-80,693
2021	$546,921	$468,520	$1,335,115	$78,401
2020	$230,042	$496,342	$1,248,500	$-266,300
2019	$899,615	$820,289	$1,485,305	$79,326
2018	$728,649	$893,709	$1,292,354	$-165,060

INTERNATIONAL SOCIETY FOR THE STUDY OF XENOBIOTICS